Look at these friendly faces, ready to chat #innovation in #genetherapy! If you are at the Alliance for Regenerative Medicine #CGMesa24 in Arizona, stroll over to booth F37 and say hello or find us in the app.
Ascend Advanced Therapies
Biotechnology Research
Ascend is a gene therapy development partner with a flexible platform featuring industry-leading analytics.
About us
Ascend is gene to GMP partner with deep expertise in gene therapy development and commercialization. We offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are at the core of our business. To set a new standard in the industry, we have invested in a world-class analytical toolkit within our flexible and scalable AAV platform of next-gen technologies, all built to find the perfect balance of yield and quality for each process. Let’s aim higher and develop the next wave of accessible life-saving therapies together!
- Website
-
https://www.ascend-adv.com/
External link for Ascend Advanced Therapies
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2021
- Specialties
- gene therapy
Locations
-
Primary
London, GB
-
Munich, DE
-
14193 NW 119th Terrace
Alachua, Florida 32615, US
Employees at Ascend Advanced Therapies
Updates
-
It is great to be in Arizona for #CGMesa24 by the Alliance for Regenerative Medicine. We were delighted to host the welcome drinks, and we are looking forward to an engaging time. Are you onsite and interested in chatting #genetherapy? Find us on the app or in Booth F37.
-
Did you hear about our new #genetherapy filling line? We are thrilled to be working with AST to expand our #commercial offer with a customized fill/finish line. Rapid, reliable filling onsite is just one more reason to work with our team. Read more about the partnership here: https://lnkd.in/g5QHTSHd
-
There's just ONE WEEK to go now for the Alliance for Regenerative Medicine #CGMesa24. Our team is thrilled to be a platinum sponsor for this impactful event that brings together senior leaders and key decision makers in #cell and #genetherapy, gene editing and tissue #engineering. Hope to see you there!
-
Q3 has been an active one here at Ascend with continued #innovation, critical hires, key #investments, and time to gather our teams across the globe. But we are not slowing down yet! We will be starting Q4 off right at the Alliance for Regenerative Medicine #CGMesa24 as a platinum sponsor. Will you be there too? https://lnkd.in/ggmDUDDt
-
When we aren't #investing and #innovating in #genetherapy (check out our latest news: https://lnkd.in/gU7Fv9da) it's not unlikely you will find us socializing! As we say goodbye to summer, and transition into fall, here are some shots from our summer socials around the globe. The best part of our team IS our team!
-
Fall is officially here, so what better time to transition into our next season at Ascend? 🍂 🌠 We are thrilled to share our news of continued #investment and expansions of capabilities and capacity at our flagship US (Alachua, FL) and EU (Munich, Germany) #genetherapy sites. Learn more in our release here or reach out any time at [email protected] with questions. https://lnkd.in/gU7Fv9da
-
Hard to believe it's been a whole month since the #CHIBioprocessingSummit, but it has! Thank you to everyone who attended the presentation by Huda Naas on Navigating the Evolution of Potency Assays and for all those who stopped by our booth to say hi. On demand access is available now if you are interested, or reach out any time to chat #genetherapy at [email protected]. See you next year in #Boston! https://lnkd.in/eqYsS33
-
It's just about go time! Are you ready to hear Ahmed Youssef and Ivana Petrovic Koshmak, PhD of Sartorius Stedim Biotech share insights on AAV process optimization and scale-up, including strategies to maximize AAV yield and ensure consistency across scales? You have a few minutes to sign up for the #webinar, but no fear if today's schedule will not allow it. You'll be able to catch us on demand to learn more about optimizing #genetherapy production or feel free to reach out any time to chat at [email protected].
Join our webinar to learn about scalable platforms and their benefits throughout an AAV product’s lifecycle: https://sar.to/ad97c #SimplifyingProgress #InThisTogether #CellandGeneTherapy
-
Just two weeks from now is a talk you will not want to miss! You're invited to join our own Ahmed Youssef as he participates in this BioProcess International #webinar with Sartorius Stedim Biotech on targeted AAV optimization for #genetherapy. How can leveraging a DOE approach maximize AAV yield and ensure consistency across scales? Register here to find out: